Dr. Guru Subramanian Guru Murthy, MD

Dr. Guru Murthy practices at Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health.

Dr. Guru Murthy's NPI, 1104172329, was assigned on July 25, 2012. Dr. Guru Murthy holds Wisconsin license 63527.

Dr. Guru Murthy's primary practice is Froedtert Hospital, at 9200 W Wisconsin Ave, Milwaukee, WI 53226 in Milwaukee County. The practice phone is (414) 805-3000.

Dr. Guru Murthy's primary practice is Froedtert Hospital in Milwaukee, Wisconsin, part of Froedtert ThedaCare Health. Dr. Guru Murthy is also affiliated with Froedtert Pleasant Prairie Hospital. The medical group on file is Froedtert & the Medical College of Wisconsin Community Physicians.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guru Murthy practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Guru Murthy's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Guru Murthy is board certified in hematology by the American Board of Internal Medicine. Dr. Guru Murthy is licensed in Wisconsin.

CMS data shows 491 Medicare services from Dr. Guru Murthy across 6 procedure codes in 2024, for 85 Medicare patients. Medicare paid $27,303 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 85 Medicare patients who saw Dr. Guru Murthy in 2024. The largest group is 65 to 74, with 46 patients. 69% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guru Murthy's median patient age at 70, with 42% women.

In 2024, Dr. Guru Murthy wrote 310 Medicare Part D claims for 57 patients. 51% of them were for generic drugs. CMS names the drug for 192 of them, across 10 drugs with 11 or more claims each, at $974,403 in total drug cost. In 2023, CMS named 246 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Guru Murthy for performance year 2024, reported as part of a group. Dr. Guru Murthy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Guru Murthy as offering telehealth.

CMS Open Payments shows 181 general payments to Dr. Guru Murthy from 23 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 61% of the total. Amgen Inc. paid the most, $28,325.